These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Evidence of HTLV-I infection in Singapore prostitutes. Sng EH, Thirumoorthy T, Levin A, Alexander S, Sng I, Blattner W. Int J STD AIDS; 1991; 2(3):172-5. PubMed ID: 1863647 [Abstract] [Full Text] [Related]
46. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins. Rudolph DL, Lal RB. Clin Chem; 1993 Feb; 39(2):288-92. PubMed ID: 7679339 [Abstract] [Full Text] [Related]
49. Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S. J Virol; 2000 Mar; 74(5):2178-85. PubMed ID: 10666247 [Abstract] [Full Text] [Related]
50. HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope. Bonis J, Preux PM, Nzisabira L, Letenneur L, Muhirwa G, Buzingo T, Kamuragiye A, Preux C, Ngoga E, Dumas M. J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1099-100. PubMed ID: 8083828 [No Abstract] [Full Text] [Related]
51. [Human T lymphotropic virus type-1, HTLV-1 provirus DNA]. Momose H, Kuramitsu M, Yamaguchi K. Nihon Rinsho; 2010 Jun; 68 Suppl 6():469-72. PubMed ID: 20942106 [No Abstract] [Full Text] [Related]
52. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean. Rouet F, Meertens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, Abid A, Strobel M, Mauclere P, Gessain A. J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036 [Abstract] [Full Text] [Related]
55. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I. Edouard E, Legrand E, Astier-Gin T, Dalibart R, Geoffre S, Dalbon P, Guillemain B, Londos-Gagliardi D. Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182 [Abstract] [Full Text] [Related]
56. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation. Hernández M, Selles ME, Pozo Peña L, Gómez I, Melchor A. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1085-8. PubMed ID: 11027594 [Abstract] [Full Text] [Related]
57. High-level Expression and One-step Purification of Chimeric Antigen Containing HTLV-I-II Diagnostic Epitopes in Escherichia coli. Bezhgi M, Fazilati M. Iran J Allergy Asthma Immunol; 2020 Apr 16; 19(2):149-158. PubMed ID: 32372628 [Abstract] [Full Text] [Related]
58. [HTLV-I and HTLV-II virus]. Maniez-Montreuil M. Ann Biol Clin (Paris); 1998 Apr 16; 56(5):563-70. PubMed ID: 9769480 [Abstract] [Full Text] [Related]
59. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region. Londos-Gagliardi D, Dalibart R, Geoffre S, Dalbon P, Pouliquen JF, Georges-Courbot MC, Sainte-Foie S, Hajjar C, Georges AJ, Moreau JP, Guillemain B. AIDS Res Hum Retroviruses; 1996 Jul 01; 12(10):941-50. PubMed ID: 8798979 [Abstract] [Full Text] [Related]